Cholestanol and survival with simvastatinBMJ 1998; 317 doi: https://doi.org/10.1136/bmj.317.7167.1252 (Published 31 October 1998) Cite this as: BMJ 1998;317:1252
More data are needed
- EJ Wallis, Research assistant,
- R Williamson, Lecturer,
- LE Ramsay, Professor,
- W W Yeo, Senior lecturer,
- P R Jackson, Reader
- Department of Clinical Pharmacology and Therapeutics, Royal Hallamshire Hospital, Sheffield S10 2JF
- Department of Medicine, University of Helsinki, PO Box 340, FIN-00029 HYKS, Helsinki, Finland
- Department of Public Health, University of Helsinki
EDITOR—Miettinen and colleagues identify a subgroup of Finnish patients with high cholestanol ratios who gained no benefit from statin treatment.1 They suggest that such patients have a low rate of cholesterol synthesis but a high rate of cholesterol absorption and that drugs that block the synthesis of cholesterol therefore do not improve survival.
Surprisingly, they presented no data on the falls in serum cholesterol concentrations observed with simvastatin treatment within each cholestanol quarter. This information is essential to fully understand the link between high cholestanol ratio and the smaller reduction …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial